B2B healthcare news outlet promotes the benefits of MyProstateScore 2.0.
LynxDx recently announced the launch of MyProstateScore 2.0 (MPS2). An article from Medical Device Network, published on February 7, 2023, highlights the convenience and precision of MPS2 and how urologists can improve their prostate screening accuracy compared to using PSA alone.
Click here to read the full article.
About Medical Device Network
Part of GlobalData, medicaldevice-network.com is one of a network of 30+ proprietary B2B websites, with an unrivalled global audience of active decision makers, influencers, and opinion leaders across the world with a combined readership of 55 million industry professionals each year.
Using technology developed at the University of Michigan, LynxDx provides best-in-class diagnostic testing services to help people live healthy and productive lives. The company’s mission is to develop superior genomic tests where there is clear patient need. LynxDx produces tests with the highest degree of accuracy and efficiency combined with an unparalleled customer experience. Learn more at LynxDx.com.